Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Lamattina John L sold 4,591 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Jun 10, 2026 · Filed Jun 12, 2026
On Jun 10, 2026, Lamattina John L (Director) sold 4,591 Ligand Pharmaceuticals Incorporated shares at an average US$250.88 for US$1.15M, leaving 26,969 shares. Filed Jun 12, 2026 (Form 4).
- Sold
- 4,591 shares
- Price
- US$250.88 average (US$247.22 to US$251.62)
- Value
- US$1.15M
- Holding after
- 26,969 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Common Stock | Sale | 257 | US$247.22 | 31,303 | Direct |
| Jun 10, 2026 | Common Stock | Sale | 232 | US$248.11 | 31,071 | Direct |
| Jun 10, 2026 | Common Stock | Sale | 697 | US$249.53 | 30,374 | Direct |
| Jun 10, 2026 | Common Stock | Sale | 3,405 | US$251.62 | 26,969 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Lamattina John L
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Lamattina John L · Jun 9, 2026
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026